Johnson & Johnson-backed cancer drug developer Aduro has filed for an initial public offering, following a $51.4m series D round in January.

Online marketplace Lamido will be shut down and absorbed into e-commerce portal Lazada in a bid to consolidate Rocket Internet's Southeast Asian activities.

The corporate-backed venture firm has upped its stake in Delivery hero to 39% and has contributed to a $110m round raised by FoodPanda.

Mobile advertising platform InMobi, which has received more than $200m in funding from SoftBank, would be valued at up to $2bn in the deal.

Cosmetic surgery chain Pengai Hospital Management is set to go public in Hong Kong after raising $13.6m from investors including IDG.

Kaiser Permanente-backed Valeritas could raise up to $80m from the initial public offering, and will use the lion's share to market its insulin delivery device.

Novartis and Johnson & Johnson-backed Catalyst has signed an agreement to form a newly merged company with Targacept, and will retain a majority stake of 65%.

The Renren-backed alternative lending platform is looking to go public later this year at a $3.5bn valuation, more than double that at which it raised money last month.

Stitch, the developer of an assistance app for salespeople, raised $3.25m in seed funding last year from investors including Google Ventures.

Deal Analysis for February